Defective proviruses rapidly accumulate during acute HIV-1 infection

Bruner, Katherine M, Murray, Alexandra J, Pollack, Ross A, Soliman, Mary G, Laskey, Sarah B, Capoferri, Adam A, Lai, Jun, Strain, Matthew C +7 more·2016·Nature Medicine
DOI 10.1038/nm.4156

Cited by (745)

Items 401–500 of 745

  1. The role of CD8 T cells in controlling HIV beyond the antigen‐specific face
    Chao Zhang, Wei Hu, JH Jin, MJ Zhou, Jin‐Wen Song, JN Deng, Lei Huang, S Y Wang, FS Wang · 2020 · HIV Medicine
  2. HIV-1 gp120 Impairs Spatial Memory Through Cyclic AMP Response Element-Binding Protein
    Jenny Shrestha, Maryline Santerre, Charles N. S. Allen, Sterling P. Arjona, Carmen Merali, Ruma Mukerjee, Kumaraswamy Naidu Chitrala, Jin Park, Asen Bagashev, Viet Bui et al. · 2022 · Frontiers in Aging Neuroscience
  3. iPS cell–derived model to study the interaction between tissue macrophage and HIV-1
    Youssef M. Eltalkhawy, Naofumi Takahashi, Yasuo Ariumi, Jun Shimizu, Kazuo Miyazaki, Satoru Senju, Shinya Suzu · 2023 · Journal of Leukocyte Biology
  4. The HIV-2 proviral landscape is dominated by defective proviruses
    Catherine Kegakilwe Koofhethile, Ce Gao, Charlotte Ajeong Chang · 2023 · AIDS
  5. Impact of chromatin on HIV-1 latency: a multi-dimensional perspective
    Joanna E. Jones, Chelsea E. Gunderson, Brian L. Wigdahl, Michael R. Nonnemacher · 2025 · Epigenetics & Chromatin
  6. The role of Tat in HIV latency and reactivation
    David M. Margolis, Edward P. Browne · 2025 · Frontiers in Immunology
  7. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses
    Keylie M. Gibson, Margaret C. Steiner, Uzma Rentia · 2020 · Viruses
  8. Challenges and Promise of Human Immunodeficiency Virus Remission
    Yijia Li, Abbas Mohammadi, Jonathan Z. Li · 2020 · The Journal of Infectious Diseases
  9. Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment
    J. Peter Svensson · 2021 · Frontiers in Cellular and Infection Microbiology
  10. CG Dinucleotide Removal in Bioluminescent and Fluorescent Reporters Improves HIV-1 Replication and Reporter Gene Expression for Dual Imaging in Humanized Mice
    Chandra Nath Roy, Mariana A. Benitez Moreno, Christopher E. Kline · 2021 · Journal of Virology
  11. Evolution during primary HIV infection does not require adaptive immune selection
    David A. Swan, Morgane Rolland, Joshua T. Herbeck, Joshua Tisdell Schiffer, Daniel B. Reeves · 2022 · Proceedings of the National Academy of Sciences
  12. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
    Alexander G. Allen, Cheng-Han Chung, Stephen D. Worrell · 2023 · Frontiers in Genome Editing
  13. Spatial technologies to evaluate the HIV-1 reservoir and its microenvironment in the lymph node
    Fatima Zaman, Melissa Laird Smith, Ashwin Balagopal, Christine M. Durand, Andrew D. Redd, Aaron A.R. Tobian · 2024 · mBio
  14. Risk factors associated with sexually transmitted infections among HIV infected men who have sex with men
    Yun Xian, Bowen Zhu, Xuan Zhang et al. · 2017 · PLoS ONE
  15. The gift of a lifetime: analysis of HIV at autopsy
    Frank M. Maldarelli · 2020 · Journal of Clinical Investigation
  16. Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs
    Gregory Dale Kirk, Jacqueline A. Astemborski, Shruti H. Mehta · 2020 · The Journal of Infectious Diseases
  17. Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?
    Alexander O. Pasternak, Christina K. Psomas, Ben Berkhout · 2021 · Frontiers in Microbiology
  18. Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1–infected patients; inhibition of its detection during ginseng-based combination therapy
    Young-Keol Cho, Jung‐Eun Kim, Jun-Hee Woo · 2019 · Journal of Ginseng Research
  19. Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models
    María Rosa López‐Huertas, Matías Morin, Nadia Madrid-Elena, Carolina Gutiérrez, Laura Jiménez-Tormo, Javier Santoyo‐López, Francisco Sanz-Rodrı́guez, Miguel Ángel Moreno-Pelayo, Laura García‐Bermejo, Santiago Moreno · 2019 · Molecular Therapy — Nucleic Acids
  20. Corrigendum to “A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice”
    Harry D. J. Knights · 2019 · AIDS Research and Treatment
  21. Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
    Xiaolei Wang, Eunice Vincent, Summer Siddiqui, Katherine Turnbull, Hong Lü, Robert V. Blair, Xueling Wu, Meagan Watkins, Widade Ziani, Jiasheng Shao et al. · 2022 · Nature Communications
  22. Age at ART initiation and proviral reservoir size in perinatal HIV-1 infection: considerations for ART-free remission
    Soumia Bekka, Kristen Kelly, Mareike Haaren · 2024 · Current Opinion in HIV and AIDS
  23. Deep Thought on the HIV Cured Cases: Where Have We Been and What Lies Ahead?
    Qing Xiao, Sanxiu He, Chaoyu Wang, Yixing Zhou, Chensi Zeng, Jun Li, Tingting Liu, Tingting Li, Xi Quan, Linyue Wang et al. · 2025 · Biomolecules
  24. Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy
    Mary Grace Katusiime, Victoria Neer, Shuang Guo, Sean C. Patro, Wenjie Wang, Brian T. Luke, Adam A. Capoferri, Xiaolin Wu, Anna M. Horner, Jason W. Rausch et al. · 2025 · Journal of Clinical Investigation
  25. Advancements in single-cell techniques for examining the HIV reservoir: pathways to a cure
    Nokuzola Mbhele, Benjamin Chimukangara, Lynn Tyers, Frank M. Maldarelli, Andrew D. Redd · 2025 · mBio
  26. Residual Immune Activation and Latency
    Elena Bruzzesi, Irini Sereti · 2018 · Current topics in microbiology and immunology
  27. DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people
    Samaa T. Gobran, Amélie Pagliuzza, Omar Khedr · 2023 · Journal of Virology
  28. HIV Expression in Infected T Cell Clones
    Jason W. Rausch, Shadab Parvez, Sachi Pathak, Adam A. Capoferri, Mary F. Kearney · 2024 · Viruses
  29. Cannabis Use Associates With Reduced Proviral Burden and Inflammatory Cytokine in Tissues From Men With Clade C HIV-1 on Suppressive Antiretroviral Therapy
    Zhou Liu, Peter Julius, Cordilia Maria Himwaze · 2024 · The Journal of Infectious Diseases
  30. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus
    Sarah Joseph, Melissa-Rose Abrahams, Matthew Moeser, Lynn Tyers, Nancie M. Archin, Amy Sondgeroth, E. Spielvogel, Ann Emery, Shuntai Zhou, Deelan Doolabh et al. · 2024 · PLoS Pathogens
  31. HIV-Tocky system to visualize proviral expression dynamics
    Omnia Reda, Kazuaki Monde, Kenji Sugata, Akhinur Rahman, Wajihah Sakhor, Samiul Alam Rajib, Sharmin Nahar Sithi, Benjy J.Y. Tan, Koki Niimura, Chihiro Motozono et al. · 2024 · Communications Biology
  32. Early HIV Infection Predictions: Role of Viral Replication Errors
    Jessica M. Conway, Alan S. Perelson · 2018 · SIAM Journal on Applied Mathematics
  33. Electrocardiographic abnormalities among people with HIV in Shanghai, China
    Fang Shen, Bowen Zhu, Yingying Ding, Meiyang Gao, Na He · 2020 · BioScience Trends
  34. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
    Widade Ziani, Jiasheng Shao, Xiaolei Wang, Kasi Russell‐Lodrigue, Yaozhong Liu, Luis J. Montaner, Ronald S. Veazey, Huanbin Xu · 2021 · Journal of Virology
  35. So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
    Adam J. Kleinman, Ivona Pandrea, Cristian Apetrei · 2022 · Viruses
  36. Measuring HIV Persistence on Antiretroviral Therapy
    Bethany A. Horsburgh, Sarah Palmer · 2018 · Advances in experimental medicine and biology
  37. HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
    Adam A. Capoferri, Ann P. Wiegand, Feiyu F. Hong, Jana L. Jacobs, Jonathan Spindler, Andrew Musick, Michael J. Bale, Wei Shao, Michele D. Sobolewski, Anthony Richard Cillo et al. · 2024 · Proceedings of the National Academy of Sciences
  38. Contribution of intact viral genomes persisting in blood and tissues during ART to plasma viral rebound in SHIV-infected rhesus macaques
    César Trifone, Corentin Richard, Amélie Pagliuzza et al. · 2025 · iScience
  39. Considerations and limitations for establishing an Intact Proviral DNA Assay (IPDA) on a chip-based digital PCR system for HIV-1 reservoir quantification
    Jasmin Tschumi, Kathrin Neumann, Dominique L. Braun, Huldrych F. Günthard, Karin Jutta Metzner · 2025 · Journal of Virological Methods
  40. Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy
    Maria Carmen Puertas, Lucía Bailón, Víctor Urrea, Maria C. García-Guerrero, Yovaninna Alarcón‐Soto, Àngel Rivero, Beatriz Mothe, José Moltó, Javier Martínez‐Picado, on behalf of the DUALITY study group · 2025 · PLoS Pathogens
  41. Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia
    Vivek Hariharan, Jennifer A. White, Filippo Dragoni, Emily J. Fray, Nicholas M. Pathoulas, Milica Moskovljevic, Hao Zhang, Anushka Singhal, Jun Lai, Subul A. Beg et al. · 2025 · Nature Microbiology
  42. Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Collagen in the Mesenteric Lymph Nodes of Nonhuman Primates
    Erin M. B. Scholz, Joseph N. Mwangi, Gabriela De la Cruz, Michael D. Nekorchuk, Chi Ngai Chan, Kathleen Busman‐Sahay, Lourdes Adamson, Paul A. Luciw, Yuri D. Fedoriw, Jacob D. Estes et al. · 2021 · Antimicrobial Agents and Chemotherapy
  43. CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection
    Olivia E. Harwood, Lea M. Matschke, Ryan V. Moriarty et al. · 2023 · PLoS Pathogens
  44. Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo
    Julie Janssens, Peggy Kim, Sun Jin Kim, Adam Wedrychowski, Gayatri Nikhila Kadiyala, Peter W. Hunt, Steven G. Deeks, Joseph K. Wong, Steven A. Yukl · 2024 · JCI Insight
  45. Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model
    Namita Satija, Foramben Patel, Gerrit Schmidt, Donald Doanman, Manav Kapoor, Annalena La Porte, Ying‐Chih Wang, Kenneth Law, Anthony M. Esposito, Kimaada Allette et al. · 2025 · Nature Communications
  46. Targeting HIV-1 proviral transcription
    Alex J. Olson, Binita Basukala, Wilson W. Wong · 2019 · Current Opinion in Virology
  47. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption
    Sara Gianella, Antoine Chaillon, Tae‐Wook Chun et al. · 2020 · Journal of Virology
  48. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients
    Alexandre Nicolas, Julie Migraine, Jacques Dutrieux, Maud Salmona, Alexandra Tauzin, Atsuko Hachiya, Jérôme Estaquier, Jean‐Michel Molina, François Clavel, Allan J. Hance et al. · 2022 · Microbiology Spectrum
  49. G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential
    Hannah O. Ajoge, Hinissan P. Kohio, Ermela Paparisto, Macon D. Coleman, Kemen Wong, Sean K. Tom, Katie L. Bain, Charles C. Berry, Eric J. Arts, Stephen Dominic Barr · 2022 · Viruses
  50. Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV
    Douglas D. Richman, Karissa Huang, Steven M. Lada · 2019 · Retrovirology
  51. Next-Generation Sequencing in a Direct Model of HIV Infection Reveals Important Parallels to and Differences from In Vivo Reservoir Dynamics
    Marilia Rita Pinzone, Maria Paola Bertuccio, Jake VanBelzen · 2020 · Journal of Virology
  52. New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment
    Thomas A. Angelovich, Melissa J. Churchill, Edwina Wright, Bruce James Brew · 2020 · Current topics in behavioral neurosciences
  53. Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
    María Rosa López‐Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, María Jesús Vivancos, Laura Luna, Santiago Moreno · 2020 · Biochemical Pharmacology
  54. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2
    Jack A. Collora, Runxia Liu, Kristen Albrecht, Ya‐Chi Ho · 2020 · Current Opinion in HIV and AIDS
  55. Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    Bonnie M. Hiener, John‐Sebastian Eden, Bethany A. Horsburgh · 2018 · Journal of Visualized Experiments
  56. A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial
    Collins C. Iwuji, Duncan R. Churchill, Stephen A. Bremner · 2020 · BMC Infectious Diseases
  57. Pinpointing recurrent proviral integration sites in new models for latent HIV-1 infection
    Ulrike C. Lange, Julia K. Bialek, Thomas Walther, Joachim Hauber · 2018 · Virus Research
  58. Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1
    Katja Klein, Immaculate Nankya, Gabrielle C. Nickel et al. · 2020 · Journal of Virology
  59. Assessing proviral competence: current approaches to evaluate HIV-1 persistence
    Aurelija Cicilionytė, Ben Berkhout, Alexander O. Pasternak · 2021 · Current Opinion in HIV and AIDS
  60. Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences
    Eva Malatinková, Jordan Thomas, Ward De Spiegelaere · 2021 · Life
  61. Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control
    Ana Moyano, Oscar Blanch-Lombarte, Laura Tarancón‐Díez et al. · 2022 · Retrovirology
  62. Marsupial satellite DNA as faithful reflections of long-terminal repeat retroelement structure
    Sakura Hayashi, Yusuke Honda, Etsuko Kanesaki · 2022 · Genome
  63. Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy
    Gabriella Rozera, Giuseppe Sberna, Giulia Berno, Cesare Ernesto Maria Gruber, Emanuela Giombini, Pietro Giorgio Spezia, Nicoletta Orchi, Vincenzo Puro, Annalisa Mondi, Enrico Girardi et al. · 2022 · Journal of Virus Eradication
  64. The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards
    Sung Yong Park, Tanzy Love, Lucy Reynell, Carl Yu, Tina Manzhu Kang, Kathryn Anastos, Jack A. DeHovitz, Chenglong Liu, Kord M. Kober, Mardge H. Cohen et al. · 2017 · Scientific Reports
  65. Delivery of gene therapy to resting immune cells for an HIV cure
    Chantelle Ahlenstiel, Stuart Grant Turville · 2019 · Current Opinion in HIV and AIDS
  66. Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis
    David Fraser Read, Edmond Atindaana, Kalyani Pyaram, Feng Yang, Sarah B. Emery, Anna Cheong, Katherine R. Nakama, Cleo Burnett, Erin T. Larragoite, Emilie Battivelli et al. · 2019 · PLoS Pathogens
  67. Phyloanatomic characterization of the distinct T cell and monocyte contributions to the peripheral blood HIV population within the host
    Brittany Rife Magalis, Samantha L. Strickland, Stephen D. Shank, Patrick Autissier, Alexandra Schuetz, Pasiri Sithinamsuwan, Sukalaya Lerdlum, James L. K. Fletcher, Mark S. de Souza, Jintanat Ananworanich et al. · 2020 · Virus Evolution
  68. Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
    Omalla Allan Olwenyi, Arpan Acharya, Nanda Kishore Routhu, Keely Pierzchalski, Jace W. Jones, Maureen A. Kane, Neil Sidell, Mahesh Mohan, Siddappa N. Byrareddy · 2020 · Cells
  69. An endogenous retrovirus presumed to have been endogenized or relocated recently in a marsupial, the red-necked wallaby
    Sakura Hayashi, Konami Shimizu, Yusuke Honda · 2022 · Genome
  70. Adaptation of lentiviral vectors for viral gene therapy and their impact on host cell biology
    Catherine W. Kaiser, Eric Christian Rouchka, Melissa L. Smith · 2026 · Journal of Translational Medicine
  71. A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy
    Aniqa Shahid, Bradley R. Jones, Maggie C. Duncan, Signe MacLennan, Michael J. Dapp, Mark H. Kuniholm, Bradley E. Aouizerat, Nancie M. Archin, Stephen J. Gange, Igho Ofotokun et al. · 2024 · Virus Evolution
  72. Comparing acute versus AIDS ART initiation on HIV-1 integration sites and clonal expansion
    Jun Wang, Nan Xiao, Zhengnong Zhu, Haiyan Qiao, Fang Zhao, Lukun Zhang, Jizhou Gou, Mengji Lu, Yun He, Hongzhou Lu et al. · 2025 · Signal Transduction and Targeted Therapy
  73. Current challenges and recent advances in the search for a cure for HIV
    Richard Brad Jones · 2019 · Journal of the International AIDS Society
  74. Biomarkers for the clinical development of antiviral therapies
    Teresa I. Ng, Patrick K. Dorr, Preethi Krishnan, Daniel E. Cohen, Susan M. Rhee, Stanley X. Wang, Melanie C. Ruzek, Federico Mensa, Warren M. Kati · 2020 · Cytometry Part B Clinical Cytometry
  75. Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells
    Michelle Y.-H. Lee, Georges Khoury, Moshe Olshansky, Secondo Sonza, Glen P. Carter, James H. McMahon, Timothy P. Stinear, Stephen J. Turner, Sharon R. Lewin, Damian F. J. Purcell · 2022 · Frontiers in Cellular and Infection Microbiology
  76. Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir
    Mithra R. Kumar, Emily J. Fray, Alexandra M. Bender · 2023 · Proceedings of the National Academy of Sciences
  77. Understanding latent HIV-1 reservoirs through host genomics approaches
    Kamil Więcek, Heng‐Chang Chen · 2023 · iScience
  78. Experimental models for HIV latency and molecular tools for reservoir quantification—an update
    Divyadarshini Angamuthu, Sandhya Vivekanandan, Luke Elizabeth Hanna · 2023 · Clinical Microbiology Reviews
  79. Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection
    Minh Ha Ngo, Joshua Pankrac, Ryan C. Y. Ho et al. · 2024 · Emerging Microbes & Infections
  80. Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules
    Gayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, Julie Janssens, Sun Jin Kim, Peggy Kim, Steven G. Deeks, Joseph K. Wong, Steven A. Yukl · 2024 · AIDS
  81. Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants
    Héloïse M Delagreverie, Maxime Grudé, Sidonie Lambert-Niclot et al. · 2019 · Journal of Antimicrobial Chemotherapy
  82. Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene
    Martin V. Hamann, Philipp Ehmele, Roxane Verdikt, Julia K. Bialek-Waldmann, Sanamjeet Virdi, Thomas Günther, Carine M. Van Lint, Adam T. Grundhoff, Joachim Hauber, Ulrike C. Lange · 2020 · Virus Research
  83. HIVIntact: a python-based tool for HIV-1 genome intactness inference
    Imogen A. Wright, Michael J. Bale, Wei Shao, Wei-Shau Hu, John M. Coffin, Gert Uves van Zyl, Mary F. Kearney · 2021 · Retrovirology
  84. Advances in basic and clinical immunology in 2016
    Javier Chinen, Yousef R. Badran, Raif S. Geha, Janet S. Chou, Ari J. Fried · 2017 · Journal of Allergy and Clinical Immunology
  85. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome
    Faezeh Borzooee, Krista D. Squires, Michael D. Grant, Mani Larijani · 2019 · Frontiers in Immunology
  86. Potential role of tyrosine kinase inhibitors during primary HIV-1 infection
    Juan Ambrosioni, Mayte Coiras, José Alcamı́ · 2017 · Expert Review of Anti-infective Therapy
  87. Discovery and Engineering of a Therapeutic Interfering Particle (TIP): a combination self-renewing antiviral
    Elizabeth J. Tanner, Seungyong Jung, Joshua Glazier, Cassandra E. Thompson, Yuqi Zhou, Benjamin Martin, Hye-In Son, James L. Riley, Leor S. Weinberger · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir
    Joanna E. Jones, Chelsea E. Gunderson, Brian L. Wigdahl, Michael R. Nonnemacher · 2026 · Viruses
  89. Antigen specificities of HIV-infected cells: A role in infection and persistence?
    Clayton Faua, Samira Fafi‐Kremer, Pierre Gantner · 2023 · Journal of Virus Eradication
  90. APOBEC3G Antagonism by Vif, or When Structure Meets Biological and Evolutionary Studies
    Yen-Li Li, Caroline A. Langley, Michael Emerman, John D. Gross · 2025 · Annual Review of Virology
  91. Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro
    Huamian Wei, Danwei Yu, Xiuzhu Geng, Yuxian He · 2020 · BMC Infectious Diseases
  92. Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses
    Hongbing Yang, Anuska Llano, Samandhy Cedeño, Annette von Delft, Angelica Corcuera, Geraldine M. A. Gillespie, Andrew Alexander Knox, Darren B. Leneghan, John Frater, Wolfgang Stöhr et al. · 2020 · Cell Reports
  93. Persistent HIV-1 transcription in CD4+ T cells from ART-suppressed individuals can originate from biologically competent proviruses
    Moira Vignoles, Viviane M. Andrade, Marc Noguera-Julián · 2021 · Journal of Virus Eradication
  94. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir
    Sean C. Patro, Aurelie Niyongabo, Frank M. Maldarelli · 2021 · Viruses
  95. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells
    Chynna M. Hendricks, Melanie N. Cash, Massimiliano S. Tagliamonte · 2022 · Microbiology Spectrum
  96. Systems crosstalk between antiviral response and cancerous pathways via extracellular vesicles in HIV-1-associated colorectal cancer
    Zimei Chen, Ke Yang, Jiayi Zhang · 2023 · Computational and Structural Biotechnology Journal
  97. For Viral Reservoir Studies, Timing Matters
    Bethany A. Horsburgh, Sarah Palmer · 2019 · Trends in Microbiology
  98. Phylogenetic analysis of HIV-1 archived DNA in blood and gut-associated lymphoid tissue in two patients under antiretroviral therapy
    Patrícia Recordon-Pinson, Camille Tumiotto, Pantxika Bellecave · 2021 · Gut Pathogens
  99. Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research
    Triana Rivera-Megias, Nhut M. Le, Alonso Heredia · 2022 · Methods in molecular biology
  100. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1
    Ashley N. Nelson, Maria L. Dennis, Jesse F. Mangold et al. · 2022 · npj Vaccines